Cymabay Therapeutics Inc (CBAY.OQ)
CBAY.OQ on NASDAQ Stock Exchange Global Select Market
12.05USD
22 Apr 2019
12.05USD
22 Apr 2019
Change (% chg)
$-0.02 (-0.17%)
$-0.02 (-0.17%)
Prev Close
$12.07
$12.07
Open
$12.08
$12.08
Day's High
$12.34
$12.34
Day's Low
$11.93
$11.93
Volume
132,347
132,347
Avg. Vol
235,883
235,883
52-wk High
$15.00
$15.00
52-wk Low
$6.33
$6.33
About
CymaBay Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies to treat metabolic diseases, including serious rare and orphan diseases. The Company's product candidates include Arhalofenate, MBX-8025 and MBX-2982. Arhalofenate is used to treat gout. MBX-8025 is a... (more)
Overall
| Beta: | 2.08 |
| Market Cap(Mil.): | $358.81 |
| Shares Outstanding(Mil.): | 43.76 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| CBAY.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 69.30 | 32.55 |
| EPS (TTM): | -1.06 | -- | -- |
| ROI: | -182.71 | 8.91 | 13.83 |
| ROE: | -308.78 | 10.06 | 15.25 |
Estimates